BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36105770)

  • 1. Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac.
    Dang J; Kong V; Li W; Navarro I; Winter JD; Malkov V; Berlin A; Catton C; Padayachee J; Raman S; Warde P; Chung P
    Tech Innov Patient Support Radiat Oncol; 2022 Sep; 23():41-46. PubMed ID: 36105770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
    Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
    Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
    Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
    Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion.
    De Bari B; Guibert G; Slimani S; Bashar Y; Risse T; Guisolan N; Trouillot J; Abel J; Weber P
    Curr Oncol; 2024 Feb; 31(2):962-974. PubMed ID: 38392066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
    Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
    Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulating an intra-fraction adaptive workflow to enable PTV margin reduction in MRIgART volumetric modulated arc therapy for prostate SBRT.
    Snyder J; Smith B; Aubin JS; Shepard A; Hyer D
    Front Oncol; 2023; 13():1325105. PubMed ID: 38260830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.
    Werensteijn-Honingh AM; Jürgenliemk-Schulz IM; Gadellaa-Van Hooijdonk CG; Sikkes GG; Vissers NGPM; Winkel D; Eppinga WSC; Intven M; Raaymakers BW; Kroon PS
    Radiother Oncol; 2021 Jan; 154():110-117. PubMed ID: 32950531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
    Waters M; Price A; Laugeman E; Henke L; Hugo G; Stowe H; Andruska N; Brenneman R; Hao Y; Green O; Robinson C; Gay H; Michalski J; Baumann BC
    Clin Transl Radiat Oncol; 2024 Jan; 44():100693. PubMed ID: 38021093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.
    de Muinck Keizer DM; Kerkmeijer LGW; Willigenburg T; van Lier ALHMW; Hartogh MDD; van der Voort van Zyp JRN; de Groot-van Breugel EN; Raaymakers BW; Lagendijk JJW; de Boer JCJ
    Radiother Oncol; 2020 Oct; 151():88-94. PubMed ID: 32622779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT.
    Faccenda V; Panizza D; Daniotti MC; Pellegrini R; Trivellato S; Caricato P; Lucchini R; De Ponti E; Arcangeli S
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
    Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
    Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy.
    Panizza D; Faccenda V; Lucchini R; Daniotti MC; Trivellato S; Caricato P; Pisoni V; De Ponti E; Arcangeli S
    Front Oncol; 2022; 12():883725. PubMed ID: 35463373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator.
    Yang J; Vedam S; Lee B; Castillo P; Sobremonte A; Hughes N; Mohammedsaid M; Wang J; Choi S
    Phys Imaging Radiat Oncol; 2021 Jan; 17():20-24. PubMed ID: 33898773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
    Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
    Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy.
    de Muinck Keizer DM; van der Voort van Zyp JRN; de Groot-van Breugel EN; Raaymakers BW; Lagendijk JJW; de Boer HCJ
    Phys Imaging Radiat Oncol; 2021 Jul; 19():90-95. PubMed ID: 34377842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMLC tracking and gating can improve dose coverage for prostate VMAT.
    Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
    Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.